Syngenta to acquire DuPont Professional Products Business

Syngenta announced today that it will acquire the DuPont Professional Products insecticide business, including a number of registered trademark brands. Created in 2002, the DuPont Professional Products insecticide business specializes in the development and marketing of innovative branded products for the professional turf and pest control markets, including Altriset, Advion® Arilon and Acelepryn®. The acquisition price is $125 million.
“This is the next step in our strategy to scale our Turf and Landscape business within Lawn and Garden to further support our customers,” said Tim Kroenke, head, Syngenta Lawn and Garden North America. “This acquisition will help Syngenta gain leadership in the professional pest management market and increase our presence in turf.”
As a result of this transaction, Syngenta can pursue opportunities in adjacent markets such as the ornamental horticulture and consumer markets. Finally, Syngenta Research & Development investment will drive growth in opportunities to extend the use of the active ingredients in the professional and home pest markets.
The transaction is subject to regulatory approval. Closing is expected in the fourth quarter of 2012.

About Syngenta
Syngenta is one of the world’s leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com
# # #
©2012 Syngenta. The Syngenta logo is a registered trademark of a Syngenta Group Company.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta’s publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.